CD4+ T cells are able to reject class I disparate allografts

Transplantation

Volumn 64, Issue 2, 1997, Pages 335-340

  Sawada, Tokihiko ^a   Wu, Yin ^a   Sachs, David H ^a   Iacomini, John ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLELE; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; EFFECTOR CELL; FEMALE; GRAFT REJECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN TRANSPLANTATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GRAFT REJECTION; GRAFT VS HOST REACTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; SKIN TRANSPLANTATION;

EID: 0030808939     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199707270-00027     Document Type: Article

References (28)

1. Auchincloss H Jr, Sachs DH. Transplantation and graft rejection. In: Paul WE, ed. Fundamental immunology. New York: Raven Press, 1993; 1099.
2. Hall BM. Cells mediating allograft rejection. Transplantation 1991; 51: 1141.
3. b mutant skin allografts differing at class I MHC. Nature 1986; 322: 829.
4. Rosenberg AS, Mizuochi T, Sharrow SO, Singer A. Phenotype, specificity and function of T cell subsets and T cell interactions involved in skin allograft rejection. J Exp Med 1987; 165: 1296.
5. Sprent J, Schaefer M, Lo D, Korngold R. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J Exp Med 1986; 163: 998.
6. Rosenberg AS, Singer A. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 1992; 10: 333.
7. Ichikawa T, Nakayama E, Uenaka A, Monden M, Mon T. Effector cells in allelic H-2 class I-incompatible skin graft rejection. J Exp Med 1987; 166: 982.
8. Rosenberg AS, Munitz TI, Maniero TG, Singer A. Cellular basis of allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ cells in vivo. J Exp Med 1991; 173: 1463.
9. Dalloul AH, Chmouzis E, Ngo K, Fung-Leung W. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate rejection of MHC class II or class I disparate skin grafts. J Immunol 1996; 156: 4114.
10. Auchincloss H, Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci USA 1993; 90: 3373.
11. Shokes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994; 15: 32.
12. Sarmiento M, Glasebrook AL, Fitch FW. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol 1980; 125: 2665.
13. Dialynas DP, Quan ZS, Wall KA, et al. Characterization of the murine T cell surface molecule designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu 3/T4 molecule. J Immunol 1984; 131: 2445.
14. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1 deficient mice have no mature B and T lymphocytes. Cell 1992; 68: 869.
15. Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Sachs DH. Characterization of mixed allogeneic chimeras: immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J Exp Med 1985; 162: 231.
16. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. Current protocols in immunology. New York: Greene and Wiley, 1994.
17. Sachs DH, Arn JS, Hansen TH. Two new recombinant H-2 haplotypes, one of which juxtaposes Kb and Ik alleles. J Immunol 1979; 123: 1965.
18. b gene shows a cluster of seven nucleotide differences. Proc Natl Acad Sci USA 1983; 80: 2007.
19. 2-microglobulin-deficient mice. J Exp Med 1992; 175: 885.
20. intermediate expression in CD8-deficient mice. Eur J Immunol 1996; 26: 213.
21. Macphail S, Stutman O. L3T4+ cytotoxic T lymphocytes specific for class I H-2 antigens are activated in primary mixed lymphocyte reactions. J Immunol 1987; 139: 4007.
22. + cytotoxic T lymphocytes. Proc Natl Acad Sci USA 1988; 85: 5205.
23. Schulz M, Schuurman HJ, Joergensen J, et al. Acute rejection of vascular heart allografts by perform deficient mice. Eur J Immunol 1995; 25: 474.
24. Nickerson P, Steurer W, Steiger J, Zheng X, Steele AW, Strom TB. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol 1994; 6: 757.
25. Kojima H, Shinohara N, Hanaoka S, et al. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1994; 1: 357.
26. Hanabuchi S, Koyanagi M, Kawasaki A, et al. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc Natl Acad Sci USA 1994; 91: 4930.
27. Ju ST, Cui H, Phaka DJ, Ettinger R, Marshak-Rothstein A. Participation of target Fas protein in apoptosis pathway induced CD4+ Th1 and CD8+ cytotoxic T cells. Proc Natl Acad Sci USA 1994; 91: 4185.
28. Stadler T, Hahn S, Erb P. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol 1994; 152: 1127.